25 related articles for article (PubMed ID: 15115902)
1. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
Simpson D; Wellington K
Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
[TBL] [Abstract][Full Text] [Related]
3. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Yao Z; Gross GJ
Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
5. The lack of bronchodilator effect and the short-term safety of cumulative single doses of an inhaled potassium channel opener (bimakalim) in adult patients with mild to moderate bronchial asthma.
Faurschou P; Mikkelsen KL; Steffensen I; Franke B
Pulm Pharmacol; 1994 Oct; 7(5):293-7. PubMed ID: 7626915
[TBL] [Abstract][Full Text] [Related]
6. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
[TBL] [Abstract][Full Text] [Related]
7. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
Burian M; Piske M; Petkovic D; Mitrovic V
Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
[TBL] [Abstract][Full Text] [Related]
8. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
9. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
Why HJ; Richardson PJ
Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of nicardipine for angina pectoris.
Pepine CJ; Lambert CR
Am J Cardiol; 1987 Jun; 59(17):13J-19J. PubMed ID: 3300237
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of KRN2391, a novel vasodilator of the nitrate-potassium channel opener hybrid type.
Ogawa N
Gen Pharmacol; 1994 Jul; 25(4):609-16. PubMed ID: 7958718
[TBL] [Abstract][Full Text] [Related]
12. Novel fluoroprostacyclin analogs with modified cycloalkylenyl chains. Highly potent and orally active anti-anginal agents.
Matsumura Y; Asai T; Shimada T; Nakayama T; Urushihara M; Morizawa Y; Yasuda A; Yamamoto T; Fujitani B; Hosoki K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):353-5. PubMed ID: 7537179
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
